Hill-Rom Holdings (Hill-Rom Holdings) Growth Rank : 0 (As of May. 05, 2024)

View and export this data going back to 1989. Start your Free Trial

What is Hill-Rom Holdings Growth Rank?

Hill-Rom Holdings has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Hill-Rom Holdings Growth Rank Related Terms

Thank you for viewing the detailed overview of Hill-Rom Holdings's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Hill-Rom Holdings (Hill-Rom Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hill-Rom Holdings Inc (NYSE:HRC) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

130 East Randolph Street, Suite 1000, Chicago, IL, USA, 60601

Website

http://www.hill-rom.com

Hill-Rom Holdings Inc is a global provider of hospital equipment and medical supplies, including hospital beds for high- and low-acuity settings. Hill-Rom reports financial data across three operating segments: patient support systems (50% of fiscal 2018 sales), front-line care (34%), and surgical solutions (16%). The firm has significant operations internationally, with roughly 30% of revenue derived from international sources and the remaining 70% from its U.S. business.

Executives

Mary Kay Ladone	officer: SVP, Corp. Dev., Strat. & IR	130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601
Deborah Rasin	officer: SVP, Chief Legal Officer	TWO PRUDENTIAL PLAZA, SUITE 4100, CHICAGO IL 60601
Paul Sherwood Johnson	officer: SVP & Pres. - PSS Acute Care	TWO PRUDENTIAL PLAZA 180 NORTH STETSON AVENUE, SUITE 4100 CHICAGO IL 60601
Andreas G Frank	officer: SVP, Pres. Front Line Care	C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Richard M Wagner	officer: Corporate Controller	221 WEST PHILADELPHIA STREET, SUITE 60W, YORK PA 17401-2991
Amy M. Dodrill	officer: President - Surgical Solutions	130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601
Gary Lee Ellis	director	THE TORO COMPANY, 8111 LYNDALE AVENUE SOUTH, BLOOMINGTON MN 55420
Mary Garrett	director	ETHAN ALLEN DRIVE, DANBURY CT 06811
Gregory J. Moore	director	130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601
William Kucheman	director	C/O DAN DUGAN, FINANCIAL PERSPECTIVES, 3025 HARBOR LN., SUITE 200, PLYMOUTH MN 55447
James R Giertz	director
Ronald A Malone	director	3 HUNTINGTON QUADRANGLE, SUITE 200S, MELVILLE NY 11747
Felicia F Norwood	director	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
William G Dempsey	director	C/O LANDAUER, INC., 2 SCIENCE ROAD, GLENWOOD IL 60425
Nancy M Schlichting	director	200 WILMOT ROAD, DEERFIELD IL 60015